Literature DB >> 24158605

[Prognosis of pregnant women with primary breast cancer].

W Harms1.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24158605     DOI： 10.1007/s00066-013-0455-6

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  5 in total

Review 1.  Breast cancer in pregnancy.

Authors:  Frédéric Amant; Sibylle Loibl; Patrick Neven; Kristel Van Calsteren
Journal:  Lancet       Date:  2012-02-11       Impact factor: 79.321

2.  Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: an observational study.

Authors:  Frédéric Amant; Kristel Van Calsteren; Michael J Halaska; Mina Mhallem Gziri; Wei Hui; Lieven Lagae; Michèl A Willemsen; Livia Kapusta; Ben Van Calster; Heidi Wouters; Liesbeth Heyns; Sileny N Han; Viktor Tomek; Luc Mertens; Petronella B Ottevanger
Journal:  Lancet Oncol       Date:  2012-02-10       Impact factor: 41.316

3.  Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study.

Authors:  Frédéric Amant; Gunter von Minckwitz; Sileny N Han; Marijke Bontenbal; Alistair E Ring; Jerzy Giermek; Hans Wildiers; Tanja Fehm; Sabine C Linn; Bettina Schlehe; Patrick Neven; Pieter J Westenend; Volkmar Müller; Kristel Van Calsteren; Brigitte Rack; Valentina Nekljudova; Nadia Harbeck; Michael Untch; Petronella O Witteveen; Kathrin Schwedler; Christoph Thomssen; Ben Van Calster; Sibylle Loibl
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

Review 4.  Use of chemotherapy during human pregnancy.

Authors:  Elyce Cardonick; Audrey Iacobucci
Journal:  Lancet Oncol       Date:  2004-05       Impact factor: 41.316

5.  DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.

Authors:  Marie-Luise Sautter-Bihl; Wilfried Budach; Jürgen Dunst; Petra Feyer; Wulf Haase; Wolfgang Harms; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer
Journal:  Strahlenther Onkol       Date:  2007-12       Impact factor: 3.621
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.